Skip to main content
. 2018 Aug 27;8:12907. doi: 10.1038/s41598-018-31212-z

Figure 2.

Figure 2

Overall survival (a) and progression-free survival (b) of 94 patients with angioimmunoblastic T-cell lymphoma according to our prognostic model. This prognostic model stratify patients into 3 groups: 0–1 risk factor (low-risk, n = 29), 2 risk factors (intermediate risk, n = 34), ≥3 risk factors (high risk, n = 31).